HOME >> MEDICINE >> NEWS
'Energy Up' demonstrates success as obesity intervention program for inner-city girls

The effectiveness of the "Energy Up" program developed by lifestyle and fitness leader Kathie Dolgin known to her students as High Voltage, has recently been evaluated in an article published in the May issue of the Journal of Adolescent Health (www.adolescenthealth.org/journal.htm). The health brief titled,"Energy Up" A Novel Approach to the Weight Management of Inner-City Teens," describes the positive results of this school-based, nutrition and fitness pilot program.

The research gathered shows that the "Energy Up" program works and is successful in dealing with behavioral issues of adolescent girls. The program under review took place at an all girl, parochial high school in New York City during the school year of 2003-2004. Participants in "Energy Up" lost a significant amount of weight. Obese girls lost the most weight while normal weight girls gained what was expected for their age. The girls changed their lifestyle by eating better, exercising more and building self-esteem.

Unlike other obesity prevention programs, "Energy Up" is not based on the health belief model which states that teens are unhealthy because they dont know certain behaviors are harmful. Instead, this novel program identifies why teens engage in unhealthy behaviors, specifically overeating, and acknowledges that many young people overeat when they know it is bad for them. "Energy Up" looks at causes, as opposed to being reactionary.

The program frames overeating within the realm of food addiction, something that no other American school based program does. Studies show that binge eating triggers the same neurological pathways as drug addiction, so Voltages theories are rooted in science. Furthermore, recent studies of carbohydrate consumption support that these foods affect satiety, and can trigger over eating.

The corner stone of "Energy Up" is the self-esteem component. Almost all other
'"/>

Contact: Claire O'Connor
oconnorpr@aol.com
212-245-5784
Claire O'Connor Public Relations, Inc.
31-May-2007


Page: 1 2

Related medicine news :

1. Long-term treatment with VYVANSE, first prodrug stimulant, demonstrates significant efficacy in ADHD
2. New study demonstrates that Lubiprostone may improve symptom relief rates in adults with IBS-C
3. Research demonstrates link between domestic violence and asthma
4. New study demonstrates nicotines role in smoking behavior
5. Study demonstrates long-term durability of Plicator procedure
6. Circumcision for prevention of HIV: new analysis demonstrates cost-effectiveness
7. Canadian study demonstrates medical induction of labor increases risk of amniotic-fluid embolism
8. ACTOS (pioglitazone HCl) demonstrates significant improvements in cardiovascular outcomes
9. Study demonstrates successful HIV-prevention program for Latino youth
10. Diabetes program demonstrates comprehensive care approach to NYC participants
11. New study demonstrates that AMITIZA (lubiprostone) may help improve symptoms

Post Your Comments:
(Date:3/6/2015)... Protein identification is increasingly being ... science research including drug discovery, diagnostics, immunology and ... was valued at $1,569.00 million in 2014 and ... 10.63% to reach $2,600.28 million in 2019. , ... protein based on protein size, shape, sequence and ...
(Date:3/6/2015)... As healthcare providers create one ... from disparate systems, they are using OnBase by ... efficiency. Enterprise content management (ECM) solutions ... IT solutions, including electronic medical records (EMR), enterprise ... , The following organizations have recently integrated ...
(Date:3/6/2015)... March 06, 2015 Saving Moses, a ... the world is traveling to Angola, Africa March 7-14 ... their malnutrition program. , This will be the organizations ... Angola, demonstrating their commitment to the region’s population by ... team will engage with the mothers and babies of ...
(Date:3/6/2015)... 06, 2015 Follow us on ... pharmacokinetics of a drug refers to testing of absorption, ... an organism. When toxicity studies are clubbed together with ... ADME/Tox. Increasing focus on lowering costs and time during ... worldwide. The traditional drug development model uses toxicity and ...
(Date:3/6/2015)... March 06, 2015 “On Tap” takes the ... the grand stage, to the silver screen and to modern ... precision toe-tapping numbers and their famous eye-high kicks! Producers, directors ... rich history of tap dancing in this robust show, showcasing ... of the United States. , “On Tap” is proud ...
Breaking Medicine News(10 mins):Health News:Protein Identification Market worth $2,600.28 Million By 2019 - New Research Report by MarketsandMarkets 2Health News:Protein Identification Market worth $2,600.28 Million By 2019 - New Research Report by MarketsandMarkets 3Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 2Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 3Health News:Saving Moses Returns to Angola to Continue Giving Infants and Children a Chance to Live 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:The Legacy Dancers, a Dazzling Dance Troupe of Former Rockettes, Kick to New Heights in “On Tap: From Broadway to the Silver Screen” 2
(Date:3/6/2015)... , March 6, 2015  Palatin Technologies, Inc. (NYSE MKT: ... 27 th Annual ROTH Conference on Wednesday, March 11, ... held at the Ritz Carlton Laguna Niguel in ... Spana , Ph.D., President and Chief Executive Officer of Palatin ... programs. About Palatin Technologies, Inc. ...
(Date:3/6/2015)... , March 6, 2015   Hospira, Inc. ... Food and Drug Administration (FDA) on today,s FDA approval of ... . This is a watershed moment for improving patient access ... leading global provider of biosimilars, Hospira has seen first-hand the ... a proud participant in these early stages of the development ...
(Date:3/6/2015)... March 6, 2015  Aethlon Medical, Inc. (OTCQB:AEMD), the ... diseases and cancer, today announced that James A. ... present a corporate overview at the 27th Annual ROTH ... time.  Aethlon was previously scheduled to present at 5:30 ... will be held at The Ritz-Carlton Hotel in ...
Breaking Medicine Technology:Hospira Statement on FDA Approval of the First Biosimilar in the United States 2Hospira Statement on FDA Approval of the First Biosimilar in the United States 3Update - Changed Time for Aethlon Medical Presentation at the 27th Annual ROTH Conference 2
Cached News: